Vanguard Group’s CAMP4 Therapeutics Corporation Common Stock CAMP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$477K Buy
328,891
+95,058
+41% +$138K ﹤0.01% 3931
2025
Q1
$935K Buy
233,833
+45,917
+24% +$184K ﹤0.01% 3732
2024
Q4
$981K Buy
+187,916
New +$981K ﹤0.01% 3770